Related Experiment Video
Updated: Aug 27, 2025

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
Published on: February 19, 2016
Current development of cabazitaxel drug delivery systems
Boyang Sun1, Jonathan F Lovell2, Yumiao Zhang1
1School of Chemical Engineering and Technology, Key Laboratory of Systems Bioengineering (Ministry of Education), Frontiers Science Center for Synthetic Biology (Ministry of Education), Tianjin University, Tianjin, China.
Abstract:
The second-generation taxane cabazitaxel has been clinically approved for the treatment of metastatic castration-resistant prostate cancer after docetaxel failure. Compared with the first-generation taxanes paclitaxel and docetaxel, cabazitaxel has potent anticancer activity and is less prone to drug resistance due to its lower affinity for the P-gp efflux pump. The relatively high hydrophobicity of cabazitaxel and the poor aqueous colloidal stability of the commercial formulation, following its preparation for injection, presents opportunities for new cabazitaxel formulations with improved features. This review provides an overview of cabazitaxel drug formulations and hydrophobic taxane drug delivery systems in general, and particularly focuses on emerging cabazitaxel delivery systems discovered in the past 5 years. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Therapeutic Approaches and Drug Discovery > Emerging Technologies.
Insights
Cabazitaxel offers potent anticancer activity for metastatic prostate cancer. Emerging nanomedicine formulations aim to overcome its hydrophobicity and improve drug delivery for better therapeutic outcomes.
Area of Science:
- Oncologic Disease Nanomedicine
- Drug Delivery Systems
- Emerging Technologies
Background:
- Cabazitaxel, a second-generation taxane, is approved for metastatic castration-resistant prostate cancer post-docetaxel failure.
- It exhibits potent anticancer activity and reduced P-gp efflux pump resistance compared to earlier taxanes.
- High hydrophobicity and poor colloidal stability of current cabazitaxel formulations necessitate advanced delivery systems.
Purpose of the Study:
- To review existing cabazitaxel drug formulations.
- To highlight novel cabazitaxel delivery systems developed in the last five years.
- To discuss general hydrophobic taxane drug delivery strategies.
Main Methods:
- Literature review of cabazitaxel formulations.
- Focus on emerging nanomedicine delivery systems.
- Analysis of hydrophobic taxane delivery advancements.
Main Results:
- Identification of various advanced cabazitaxel formulations.
- Overview of recent innovations in hydrophobic drug delivery.
- Discussion of formulation strategies to enhance cabazitaxel stability and efficacy.
Conclusions:
- Emerging nanomedicine approaches show promise for improved cabazitaxel delivery.
- New formulations can potentially overcome limitations of current cabazitaxel treatments.
- Further research into advanced drug delivery systems is crucial for cabazitaxel efficacy.
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drugs that Stabilize Microtubules
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Delivery: Enteral Route
Drug Distribution: Tissue Binding
For...

